Annual Review of Pharmacology and Toxicology

Annual Review of Pharmacology and Toxicology

ANNU REV PHARMACOL
影响因子:13.1
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Annual Reviews Inc.
发刊时间:1976
发刊频率:Annual
收录数据库:SCIE/Scopus收录
ISSN:0362-1642

期刊介绍

The Annual Review of Pharmacology and Toxicology, in publication since 1961, covers the significant developments in the fields of pharmacology and toxicology, including receptors, transporters, enzymes, and chemical agents; drug development science; systems such as the immune system, central and autonomic nervous systems, gastrointestinal system, cardiovascular system, endocrine system, and pulmonary system; and special topics.
《药理学和毒理学年度回顾》自1961年出版以来,涵盖了药理学和毒理学领域的重大发展,包括受体、转运蛋白、酶和化学试剂;药物开发科学;系统如免疫系统、中枢和自主神经系统、胃肠系统、心血管系统、内分泌系统和肺系统;和专题。
年发文量 28
国人发稿量 1.81
国人发文占比 0.06%
自引率 -
平均录取率0
平均审稿周期 约稿?周期不定
版面费 -
偏重研究方向 医学-毒理学
期刊官网 http://www.annualreviews.org/journal/pharmtox
投稿链接

期刊高被引文献

Therapeutic Oligonucleotides: State of the Art.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021050
Environmental Obesogens: Mechanisms and Controversies.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021304
Modulating NRF2 in Disease: Timing Is Everything.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021856
The Exposome: Molecules to Populations.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021315
Pharmacologic Targeting of Hypoxia-Inducible Factors.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021637
Organoids for Drug Discovery and Personalized Medicine.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021108
Metals and Mechanisms of Carcinogenesis.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021031
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010617-052811
Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021358
The Placebo Effect in Pain Therapies.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021542
The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021701
Lipid-Dependent Regulation of Ion Channels and G Protein-Coupled Receptors: Insights from Structures and Simulations.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023411
Therapeutic Approaches to the Treatment of Tinnitus.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021556
Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010716-104727
Novel Clinical Toxicology and Pharmacology of Organophosphorus Insecticide Self-Poisoning.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021842
Systems Pharmacology: Defining the Interactions of Drug Combinations.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021511
Beyond THC and Endocannabinoids.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021441
Muscle Wasting Diseases: Novel Targets and Treatments.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021041
Assessment of Pharmacokinetic Drug-Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021909
Big Data and Artificial Intelligence Modeling for Drug Discovery.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023324
Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021818
Challenges in Orphan Drug Development: Identification of Effective Therapy for Thyroid-Associated Ophthalmopathy.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010617-052509
Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023420
Proteasome Inhibitor Drugs.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023603
Recent Developments in Understanding Barrier Mechanisms in the Developing Brain: Drugs and Drug Transporters in Pregnancy, Susceptibility or Protection in the Fetal Brain?
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021430
Surviving in the Valley of Death: Opportunities and Challenges in Translating Academic Drug Discoveries.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021625
Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023654
Unlocking Personalized Biomedicine and Drug Discovery with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Fit for Purpose or Forever Elusive?
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023309
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023537
(Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023711
Levering Mechanically Activated Piezo Channels for Potential Pharmacological Intervention.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023703
Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021807
Role of Cell Death in Toxicology: Does It Matter How Cells Die?
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021725
Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023301
Moving from the Trial to the Real World: Improving Medication Adherence Using Insights of Implementation Science.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021348
β2 Adrenergic Receptor Complexes with the L-Type Ca2+ Channel CaV1.2 and AMPA-Type Glutamate Receptors: Paradigms for Pharmacological Targeting of Protein Interactions.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023404
Gene-Based Dose Optimization in Children.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023459
Artificial Intelligence in Drug Treatment.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023746
G Protein-Coupled Receptor Pharmacology at the Single-Molecule Level.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023348
Barriers to Ensuring Access to Affordable Prescription Drugs.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010919-023518
Drug Therapies for Chronic Cholestatic Liver Diseases.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021059
Prospects for Diminishing the Impact of Nonamyloid Small-Vessel Diseases of the Brain.
来源期刊:Annual review of pharmacology and toxicologyDOI:10.1146/annurev-pharmtox-010818-021712

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
0.00%50.55%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
PHARMACOLOGY & PHARMACY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学1区
PHARMACOLOGY & PHARMACY 药学
1区
TOXICOLOGY 毒理学
1区
2023年12月升级版
医学1区
PHARMACOLOGY & PHARMACY 药学
1区
TOXICOLOGY 毒理学
1区
2022年12月旧的升级版
医学1区
PHARMACOLOGY & PHARMACY 药学
1区
TOXICOLOGY 毒理学
1区